Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Cibinqo

Active ingredient: Abrocitinib

Neutral reference profile for an independent medicine-access consultancy enquiry about Cibinqo (Abrocitinib). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Cibinqo used for?

Cibinqo (abrocitinib) is a JAK inhibitor indicated to treat moderate-to-severe atopic dermatitis, or eczema, in adults and adolescents 12 years and older who are candidates for systemic therapy.

It is available in film-coated tablets form, each containing 100 mg or 200 mg abrocitinib.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Cibinqo identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordCibinqo
Active ingredientAbrocitinib
Dosage formfilm-coated tablets
Recorded options8
Directory areaDermatology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 50 mg · 28 tablets Catalogue organisation: Pfizer Pharma GmbH
  2. 50 mg · 91 tablets Catalogue organisation: Pfizer Pharma GmbH
  3. 100 mg · 14 tablets Catalogue organisation: Pfizer Pharma GmbH
  4. 100 mg · 28 tablets Catalogue organisation: Pfizer Pharma GmbH
  5. 100 mg · 91 tablets Catalogue organisation: Pfizer Pharma GmbH
  6. 200 mg · 14 tablets Catalogue organisation: Pfizer Pharma GmbH
  7. 200 mg film-coated tablets · 28 tablets Catalogue organisation: Abacus Medicine A/S
  8. 200 mg film-coated tablets · 91 tablets Catalogue organisation: EurimPharm Arzneimittel GmbH

OFFICIAL SOURCES

Check the Cibinqo record at an official source.

Search for “Cibinqo” or “Abrocitinib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Cibinqo.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Cibinqo

01What is Cibinqo?

This directory record associates the brand name Cibinqo with the active ingredient Abrocitinib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Cibinqo strengths and packs are recorded?

The catalogue currently shows: 50 mg · 28 tablets; 50 mg · 91 tablets; 100 mg · 14 tablets; 100 mg · 28 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Cibinqo?

Catalogue records currently name: Pfizer Pharma GmbH, Abacus Medicine A/S, EurimPharm Arzneimittel GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Cibinqo?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Cibinqo, payment request, stock guarantee or binding offer.

06Can I buy Cibinqo from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.